Senior Director, Business Development

Quotient Sciences•San Diego, CA

15h•Remote

About The Position

Quotient Sciences is seeking a commercially driven Senior Director of Business Development to lead growth across its West Coast territory, with a focus on new business for Translational Pharmaceutics® and Clinical Pharmacology services. The role is responsible for identifying, developing, and securing opportunities across Quotient Sciences' integrated CRDMO offering, serving emerging biotech, specialty pharma, and large pharmaceutical organizations. The successful candidate will sell integrated development solutions that combine formulation development, on-demand GMP manufacturing, and clinical pharmacology. The role requires strong market awareness across early development, clinical pharmacology, and drug product development, along with a hunter mentality, commercial acumen, and the ability to build strategic client relationships. The position reports to the Executive Director, Business Development. The role is remote in the West Coast, United States, is full-time and exempt, and requires travel of up to 50%. Travel includes visits throughout the territory, attendance at industry conferences, and visits to Quotient Sciences' US and UK facilities.

Requirements

Bachelor's degree in Life Sciences, Business, or a related discipline, or equivalent experience.
Significant business development, sales, or commercial account management experience within the pharmaceutical services sector.
Demonstrated success selling CRO, CDMO, or integrated CRDMO services.
Proven track record of generating new business and consistently delivering revenue growth.
Experience managing complex pharmaceutical development opportunities through contract execution.
Strong understanding of the drug development lifecycle, particularly in early development environments.
Excellent communication, presentation, negotiation, and relationship-management skills.
Experience using Salesforce or a comparable CRM platform.
Ability and willingness to travel up to 50%.
Applicants must be at least 18 years old and must not have been debarred by the FDA.

Nice To Haves

Experience selling Clinical Pharmacology, Phase I clinical research, drug product development, formulation development, or manufacturing services.
Strong understanding of small molecule drug development.
Experience selling integrated development solutions involving multiple service lines.
Existing relationships within West Coast pharmaceutical and biotechnology companies.
Understanding of the strategic value of accelerating programs through integrated development models such as Translational Pharmaceutics®.

Responsibilities

Develop and execute a territory strategy aligned with revenue, growth, and market penetration objectives.
Drive new business opportunities across Quotient Sciences' integrated CRDMO service offering.
Promote and position Translational Pharmaceutics® and Clinical Pharmacology services to pharmaceutical and biotechnology companies.
Identify, qualify, and secure new business opportunities across formulation development, clinical pharmacology, GMP manufacturing, and commercial supply services.
Build and maintain senior-level relationships with scientific, operational, and executive stakeholders.
Educate customers on the value of integrating development, manufacturing, and clinical testing within a single partner model.
Lead the sales lifecycle from opportunity identification through proposal development, negotiation, and contract execution.
Partner with technical, operational, and scientific teams to develop compelling client solutions.
Drive territory growth while maintaining commercially appropriate project margins.
Lead customer presentations, commercial negotiations, and strategic business reviews.
Expand existing customer relationships while continually generating opportunities with new clients.
Maintain accurate pipeline, forecasting, and account information within Salesforce.
Represent Quotient Sciences at conferences, partnering events, trade shows, and customer meetings.
Remain informed of industry developments, competitive activity, emerging technologies, and market trends within the small molecule development landscape.